GENPHARMASEC LIMITED

BSE: GENPHARMA531592ISIN INE861N01036

Services
Trading & Distributors

Share price

₹1.09+0.05 (+4.81%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹1.64
52W low: ₹0.75
Off 52W high: -33.54%
1M return: -0.91%
3M return: +3.81%
6M return: -12.10%
1Y return: -30.57%
20D avg volume: 4,44,879
50 DMA: ₹1.08
200 DMA: ₹1.12

Key ratios Consolidated

Market cap: ₹60.36 Cr
Current price: ₹1.09
52W high / low: ₹1.64 / ₹0.75
Face value: ₹1.00
P/E: 43.86
P/B: 0.89
EPS (TTM): ₹0.02
Book value / share: ₹1.22
ROE: —
ROCE: 2.40%
Operating margin: —
Net margin: —
Debt / equity: 0.50
Net debt: ₹32.00 Cr
Interest cover: 1.78
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 30.1 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	85.66	49.71	55.43	39.83	32.64	12.04	14.01	8.48	6.03	5.20	—
	1.06	0.37	1.02	0.98	0.47	0.69	0.94	0.81	0.75	0.57	—
	86.72	50.08	56.45	40.81	33.10	12.74	14.95	9.30	6.78	5.76	—
	85.14	49.83	54.59	42.14	33.90	11.49	15.37	8.00	6.28	5.28	—
	1.69	1.06	0.12	1.70	0.89	0.13	0.38	0.02	0.11	—	—
	74.63	47.48	46.55	33.85	39.78	10.75	9.49	7.88	5.36	5.67	—
	1.12	1.11	1.07	1.25	1.20	0.35	0.31	0.31	0.19	0.18	—
	0.44	0.40	0.48	0.41	0.23	0.12	0.11	0.16	0.07	0.10	—
	0.68	0.67	0.68	0.67	0.56	0.27	0.26	0.10	0.30	0.16	—
	3.23	1.70	2.22	2.06	1.54	0.92	0.74	1.01	0.73	0.69	—
	1.58	0.26	1.85	-1.33	-0.80	1.25	-0.43	1.29	0.51	0.49	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	1.58	0.26	1.85	-1.33	-0.80	1.25	-0.43	1.29	0.51	0.49	—
	0.55	0.43	0.50	0.50	0.38	0.03	-0.15	0.51	0.20	0.20	—
	1.03	-0.17	1.35	-0.83	-1.18	1.22	-0.27	0.78	0.70	0.29	—
	0.01	0.00	0.02	-0.02	-0.02	0.02	-0.01	0.01	0.01	0.01	—
Key metrics
	2.70	1.33	3.01	-0.25	-0.01	1.64	-0.06	1.55	0.88	0.75	—
	3.20%	2.70%	5.40%	-0.60%	0.00%	13.60%	-0.40%	18.30%	14.60%	14.40%	—
	1.20%	-0.30%	2.40%	-2.10%	-3.60%	10.10%	-1.90%	9.20%	11.60%	5.60%	—
	2.70%	—	2.60%	—	-0.80%	—	-0.50%	—	—	—	—
	162.40%	312.90%	295.60%	369.70%	441.30%	131.50%	—	—	—	—	—
	187.30%	-113.90%	600.00%	-206.40%	-268.60%	320.70%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	230.63	139.94	33.72	—
	3.43	3.16	3.06	—
	234.06	143.09	36.78	—
	231.70	142.12	34.90	—
	4.57	2.84	0.87	—
	202.51	131.40	28.07	—
	4.55	3.87	0.99	—
	1.73	1.24	0.43	—
	2.70	2.17	0.81	—
	9.21	6.27	3.12	—
	2.36	0.97	1.88	—
	0.00	0.00	0.00	—
	2.36	0.97	1.88	—
	1.98	0.41	0.65	—
	1.38	0.56	1.23	—
	0.01	0.01	0.01	—
Key metrics
	6.79	4.38	3.12	—
	2.94%	3.10%	9.30%	—
	0.60%	0.40%	3.60%	—
	—	2.40%	3.30%	—
	243.35%	315.00%	—	—
	150.91%	-54.50%	—	—
	—	-18.07	-2.71	—
	—	-31.34	2.44	—
	—	0.50	0.05	—
	—	32.00	2.50	—
	—	30.1	146.6	—
Balance sheet
	—	138.15	79.89	—
	—	80.52	28.16	—
	—	0.97	0.65	—
	—	29.27	13.60	—
	—	13.88	8.20	—
	—	26.06	0.24	—
	—	21.31	5.56	—
	—	31.59	8.26	—
	—	47.03	9.84	—
	—	32.97	3.15	—
	—	9.00	0.00	—
	—	23.97	3.15	—
	—	65.64	65.28	—
Cash flow
	—	-17.55	3.00	—
	—	13.26	-15.31	—
	—	3.92	-1.25	—
	—	0.52	5.71	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	50.83	44.78	51.66	36.01	31.56	12.11	13.56	8.34	5.77	5.30	—
	1.66	0.97	1.62	1.43	1.00	0.82	1.06	0.93	0.86	0.58	—
	52.50	45.76	53.28	37.44	32.56	12.94	14.62	9.27	6.63	5.88	—
	49.43	43.66	50.42	36.95	31.18	11.23	14.65	7.53	5.60	5.15	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	44.65	45.31	46.55	33.85	39.78	10.75	9.76	7.88	5.36	5.47	—
	0.26	0.24	0.25	0.22	0.19	0.21	0.18	0.18	0.14	0.17	—
	0.16	0.13	0.25	0.19	0.08	0.08	0.06	0.11	0.04	0.07	—
	0.10	0.10	0.09	0.07	0.04	0.04	0.04	0.05	0.04	0.00	—
	0.78	0.37	0.79	0.48	0.35	0.85	0.66	0.82	0.60	0.62	—
	3.06	2.10	2.86	0.49	1.38	1.71	-0.04	1.74	1.03	0.73	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	3.06	2.10	2.86	0.49	1.38	1.71	-0.04	1.74	1.03	0.73	—
	0.49	0.53	0.55	-0.27	0.56	0.15	0.19	0.61	0.03	0.14	—
	2.57	1.57	2.32	0.76	0.82	1.56	-0.23	1.13	1.00	0.59	—
	0.05	0.03	0.04	0.01	0.01	0.03	-0.01	0.02	0.02	0.01	—
Key metrics
	3.32	2.33	3.20	0.75	1.50	1.83	0.06	1.90	1.11	0.80	—
	6.50%	5.20%	6.20%	2.10%	4.80%	15.10%	0.40%	22.80%	19.20%	15.10%	—
	5.10%	3.50%	4.50%	2.10%	2.60%	12.90%	-1.70%	13.50%	17.30%	11.10%	—
	4.00%	—	4.10%	—	2.00%	—	0.00%	—	—	—	—
	61.10%	269.80%	281.00%	331.80%	447.00%	128.50%	—	—	—	—	—
	213.40%	0.60%	1,108.70%	-32.70%	-18.00%	164.40%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	183.28	131.35	32.96	—
	5.68	4.87	3.43	—
	188.98	136.22	36.39	—
	180.46	129.78	32.95	—
	0.00	0.00	0.00	—
	170.36	131.40	28.47	—
	0.97	0.97	0.67	—
	0.73	0.59	0.28	—
	0.36	0.26	0.13	—
	2.42	1.89	2.72	—
	8.51	6.44	3.45	—
	0.00	0.00	0.00	—
	8.51	6.44	3.45	—
	1.30	0.99	0.98	—
	7.22	5.45	2.47	—
	0.13	0.10	0.04	—
Key metrics
	9.60	7.29	3.86	—
	5.24%	5.60%	11.70%	—
	3.94%	4.10%	7.50%	—
	—	9.20%	5.30%	—
	179.52%	298.50%	—	—
	120.12%	120.60%	—	—
	—	1.89	3.44	—
	—	0.35	1.40	—
	—	0.05	0.05	—
	—	3.14	2.63	—
	—	29.2	147.7	—
Balance sheet
	—	110.06	79.09	—
	—	61.77	27.83	—
	—	0.79	0.52	—
	—	28.02	13.39	—
	—	12.58	8.14	—
	—	1.36	0.22	—
	—	0.11	0.09	—
	—	30.13	8.19	—
	—	33.80	9.26	—
	—	3.93	3.15	—
	—	0.00	0.00	—
	—	3.93	3.15	—
	—	71.50	66.55	—
Cash flow
	—	1.93	3.45	—
	—	-1.64	-16.45	—
	—	-0.02	-0.44	—
	—	0.04	0.01	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +179.52%
Profit YoY (TTM): +120.12%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +243.35%
Profit YoY (TTM): +150.91%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 32.06%

Quarter	September 2026	June 2026
Promoter %	32.06%	29.98%

Holder	Type	Holding	Previous	Change
SNEHA SADHWANI	Promoter	16.80%	16.80%	0.00%
RAJESH SADHWANI	Promoter	15.26%	13.18%	+2.08%
RUSHABH SEVANTILAL SANGHAVI	Public	3.42%	4.42%	-1.00%
SADASHIV KANYANA SHETTY	Public	2.06%	2.06%	0.00%
VISHESH MAHESH NIHALANI	Public	1.52%	1.52%	0.00%
L7 HITECH PRIVATE LIMITED	Public	1.24%	1.17%	+0.07%
NARENDRA CHHAGANLAL SOLANKI	Public	1.09%	1.09%	0.00%
NIMESH SHAMBHULAL JOSHI	Public	1.01%	1.01%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Redington Limited	28,660	366.60	18.17	19.00%	+31.26% TTM	-17.17% TTM	+46.46%
MMTC Ltd.	8,025	53.50	17.94	21.60%	-19.71% TTM	+355.55% TTM	-20.53%
MSTC Limited	4,106	583.25	17.52	31.80%	+21.02% TTM	-44.88% TTM	+6.22%
CREATIVE NEWTECH LIMITED	2,094	1,394.20	25.97	26.40%	—	—	—
Pervasive Commodities Limited S	1,137	12.62	74.24	0.00%	+111.30% TTM	+197.12% TTM	—
BN AGROCHEM LIMITED	1,117	114.20	65.40	4.20%	+84.51% TTM	-60.97% TTM	-68.29%
RRP DEFENSE LIMITED S	802	584.75	-330.37	-8.00%	+39.37% TTM	-364.13% TTM	-35.71%
The Yamuna Syndicate Ltd	750	24,400.00	8.22	0.30%	+11.33% TTM	-16.43% TTM	-32.22%
Shiv Aum Steels Limited	741	545.00	—	—	—	—	—
Riddhi Siddhi Gluco Biols Ltd	636	670.90	-27.71	2.80%	-37.98% TTM	+38.40% TTM	+20.31%
State Trading Corporation of India	624	104.00	—	-16.70%	—	—	-21.92%
Arvaya Healthcare Limited S	569	118.45	-311.71	-2.10%	-47.37% TTM	-2,742.86% TTM	+148.22%
Oswal Agro Mills Ltd.	548	40.86	-15.96	1.50%	-99.98% TTM	-127.15% TTM	-46.29%
SMT ENGINEERING LIMITED	459	254.15	18.72	24.80%	+248.17% TTM	+377.43% TTM	+169.03%
Filtron Engineers Ltd. S	451	71.04	1,420.80	0.30%	-100.00% TTM	+363.64% TTM	+67.00%
Kothari Products Ltd.	364	61.00	18.72	1.60%	+7.57% TTM	+124.93% TTM	-32.00%
Balgopal Commercial limited	337	145.00	-62.76	-12.50%	-96.08% TTM	-231.62% TTM	-35.47%
PIPAN OILS LIMITED S	323	184.25	-118.11	-191.70%	—	-1,342.11% TTM	+35.19%
VEGA JEWELLERS LIMITED S	315	61.95	10.45	31.50%	+465.43% TTM	+873.55% TTM	+60.24%
Novalum Materials Limited S	307	46.74	274.94	7.70%	+290.48% TTM	+239.39% TTM	+36.63%
Sakuma Exports Ltd.	285	1.82	26.72	1.80%	-13.44% TTM	-0.93% TTM	-34.53%
Parshva Enterprises Limited	254	249.05	950.47	3.60%	+0.24% TTM	+8.33% TTM	+32.09%
Polo Queen Industrial and Fintech Limited	253	7.54	110.89	2.50%	-2.02% TTM	-15.56% TTM	-79.87%
Sicagen India Limited	225	56.94	8.91	7.40%	+29.43% TTM	+50.03% TTM	-9.42%
Chandrima Mercantiles limited S	218	6.55	-163.75	4.30%	-69.52% TTM	-134.73% TTM	-34.63%
GENPHARMASEC LIMITED	60	1.09	43.86	2.40%	+243.35% TTM	+150.91% TTM	-30.57%

Filings & corporate actions

Recent announcements

Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th September, 2026.3 Nov 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026.3 Nov 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
Unaudited Standalone & consolidated Financial Result of the company for the quarter & half year ended 30th September 2026.3 Nov 2026 · Result / Financial Results
Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026.3 Nov 2026 · Board Meeting / Outcome of Board Meeting
Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited ....29 Oct 2026 · Board Meeting / Board Meeting
Intimation under regulation 30 - Change of name of Subsidiary of the company.14 Oct 2026 · Company Update / General
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.5 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Disclosure of Voting Results and Scrutinizers report of the 34th Annual General Meeting held on 29th September, 2026.30 Sep 2026 · AGM/EGM / AGM
Submission of Proceeding of the 34th Annual General Meeting of the Member of the Genpharmasec Ltd held on Tuesday, 29th September, 2026.29 Sep 2026 · AGM/EGM / AGM
Intimation of Closure of Trading window.26 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication of Notice of AGM to be held on 29th September, 2026.8 Sep 2026 · Company Update / Newspaper Publication
Annual Report for Financial Year 2025-26.7 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of 34th Annual General Meeting of the company to be held on September 29, 2026.7 Sep 2026 · AGM/EGM / AGM
Intimation of Book Closure for AGM to be held on 29th September, 2026.2 Sep 2026 · Corp. Action / Book Closure
Outcome of the Meeting of Board of Directors held on Wednesday, 02nd September, 2026.2 Sep 2026 · Company Update / Change in Management
Outcome of the Meeting of Board of Directors held on Wednesday, 02nd September, 2026.2 Sep 2026 · Board Meeting / Outcome of Board Meeting
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Sadhwani & PACs2 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Sadhwani31 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve 1. To Fix the Day, Date, Time ....28 Aug 2026 · Board Meeting / Board Meeting
Regarding Recent Agreement with Amneal Healthcare Private Limited13 Aug 2026 · Company Update / Press Release / Media Release
Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2026.13 Aug 2026 · Company Update / Newspaper Publication
Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th June, 2026.11 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Unaudited Standalone & Consolidated Financial Results of the company for the quarter ended 30th June, 2026.11 Aug 2026 · Result / Financial Results
Outcome of the Meeting of Board of Directors held on Tuesday, 11th August, 2026.11 Aug 2026 · Board Meeting / Outcome of Board Meeting
Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited ....3 Aug 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended June 30, 2026.7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading Window26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Annual Secretarial Compliance Report for the year ended March 31, 2026.27 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Newspaper Publication of Audited Financial Result for the quarter and year ended 31st March, 2026.23 May 2026 · Company Update / Newspaper Publication
Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st March, 2026.21 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Audited Standalone & Consolidated Financial Results of the company for the Quarter and Financial year Ended 31st March, 2026.21 May 2026 · Result / Financial Results
Outcome of the Meeting of Board of Directors held on Thursday, May 21, 2026.21 May 2026 · Board Meeting / Outcome of Board Meeting
Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1. To consider, approve & take ....13 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....14 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended March 31, 2026.8 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of closure of Trading window.26 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Outcome of Separate Meeting of Independent Directors held on March 24, 2026.24 Mar 2026 · Company Update / General
Newspaper Publication of Unaudited Financial Result for the quarter ended December 31, 2025.11 Feb 2026 · Company Update / Newspaper Publication
Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st December, 2025.9 Feb 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Unaudited Standalone & Consolidated Financial Result of the company for the quarter ended December 31, 2025.9 Feb 2026 · Result / Financial Results

Board meetings

3 Nov 2026 Board Meeting - Financial Results
11 Aug 2026 Board Meeting - Financial Results